General
India orders top drugmaker to halt eye medicine production at plant over quality lapses
CNA
Published 30 Oct 2026, 11:55 pm·1 h ago·1 min read
Listen to this story
Read aloud by your device
Indian regulators have escalated action against India's largest drugmaker, Sun Pharma, barring ophthalmic drug production at its Assam factory until it submits a satisfactory compliance report.
Read the full story at CNA
channelnewsasia.com